Market Overview

Aegis Capital Maintains Buy on Ironwood Pharmaceuticals, Inc., Raises PT to $19.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for IRWD

DateFirmActionFromTo
Dec 2017MizuhoDowngradesBuyNeutral
Nov 2017Credit SuisseInitiates Coverage OnOutperform
Jul 2017JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for IRWD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (IRWD)

Partner Center